India to Australia: Montelukast Export Trade Route

The India to Australia Montelukast corridor is one of India's established pharmaceutical export routes, with 81 shipments documented worth a combined $1.5M USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 57% of all export value, reflecting the consolidated nature of India's montelukast manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $19.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 23.5%, placing it at rank #10 among India's top montelukast export destinations globally.

On the import side, key buyers of Indian montelukast in Australia include SANDOZ PTY LIMITED, SANDOZ PTY LTD , SANDOZ PTY LTD and 10 others. SANDOZ PTY LIMITED is the single largest importer with 7 shipments valued at $367.4K USD.

India's montelukast exports to Australia are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 55 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD — together account for 100% of total trade value on this route. The average shipment value of $19.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru.& med.: montelukast sandoz 10mg t and pharm drugs medicine montelukast sandoz10 each fct cont montelukast sod eq to montelukast 10mg b no d2203332d m dec 22, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SANDOZ PTY LIMITED is the largest importer with 7 shipments worth $367.4K USD — representing 24% of all montelukast imports from India on this route. A total of 13 buyers are active on this corridor.